Optafenac

Optafenac0.1%

Ophthalmic Suspension

Nepafenac

Popular Pharmaceuticals Ltd.

Product Code : 12555
MRP 150.00
10% Off
Best PriceTk
/
1
Section

Medicine overview

Indications of Optafenac 0.1%

Optafenac 0.1% 0.1% Sterile Ophthalmic Suspension: The treatment of post-operative ocular pain and inflammation including cataract surgery Inhibition of surgery induced miosis and Prevention of post-operative cystoid macular edema (CME).Optafenac 0.1% 0.3% Sterile Ophthalmic Suspension: Post-operative pain and inflammation associated with cataract surgery.

Theropeutic Class

Ophthalmic Non-Steroid drugs

Pharmacology

Optafenac 0.1% is a nonsteroidal anti-inflammatory prodrug (NSAID). After instillation in the eye, it penetrates the cornea and is converted by ocular tissue hydrolase to Amfenac, a potent nonsteroidal anti-inflammatory drug. Amfenac is thought to inhibit the action of cyclooxygenase enzyme. This enzyme is required for prostaglandin synthesis.

Dosage & Administration of Optafenac 0.1%

Optafenac 0.1% 0.1% Sterile Ophthalmic Suspension- For post-operative pain & inflammation: Instill 1 drop 3 times daily 1 day prior to cataract surgery and continued on the day of surgery and through the first 2 weeks of the post-operative period. For surgery induced miosis: Instill 1 drop 3 times daily 1 day before surgery & on the day of surgery. For prevention of post-operative CME: Instill 1 drop 3 times daily 1 day before surgery and continued on the day of surgery and through the first 6 weeks of the post-operative period. Optafenac 0.1% 0.3% Sterile Ophthalmic Suspension- For post-operative pain & inflammation: Instill 1 drop once daily 1 day prior to cataract surgery and continued on the day of surgery and through the first 2 weeks of the post-operative period. An additional drop should be administered 30 to 120 minutes prior to surgery.

Dosage of Optafenac 0.1%

Optafenac 0.1% 0.1% Sterile Ophthalmic Suspension- For post-operative pain & inflammation: Instill 1 drop 3 times daily 1 day prior to cataract surgery and continued on the day of surgery and through the first 2 weeks of the post-operative period. For surgery induced miosis: Instill 1 drop 3 times daily 1 day before surgery & on the day of surgery. For prevention of post-operative CME: Instill 1 drop 3 times daily 1 day before surgery and continued on the day of surgery and through the first 6 weeks of the post-operative period. Optafenac 0.1% 0.3% Sterile Ophthalmic Suspension- For post-operative pain & inflammation: Instill 1 drop once daily 1 day prior to cataract surgery and continued on the day of surgery and through the first 2 weeks of the post-operative period. An additional drop should be administered 30 to 120 minutes prior to surgery.

Contraindications

Contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formulation or to other NSAIDs.

Side Effects of Optafenac 0.1%

Reported side effects are foreign body sensation, lid margin crusting, ocular discomfort, ocular hyperemia etc.

Pregnancy & Lactation

Use in pregnancy: There are no adequate and well-controlled studies in pregnant women. Optafenac 0.1% should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.Use in lactation: It is not known whether this drug is excreted in human milk. So, caution should be exercised when Optafenac 0.1% ophthalmic suspension is administered to a nursing mother.

Precautions & Warnings

Optafenac 0.1% should be used with caution in patients with known bleeding tendencies or who are receiving medications which may prolong bleeding time.

Use In Special Populations

Use in children: Safety and effectiveness in pediatric patients below 18 years of age have not been established.Use in elderly patients: No overall differences in safety or effectiveness have been observed between elderly and younger patients.

Drug Classes

Ophthalmic Non-Steroid drugs

Mode Of Action

Optafenac 0.1% is a nonsteroidal anti-inflammatory prodrug (NSAID). After instillation in the eye, it penetrates the cornea and is converted by ocular tissue hydrolase to Amfenac, a potent nonsteroidal anti-inflammatory drug. Amfenac is thought to inhibit the action of cyclooxygenase enzyme. This enzyme is required for prostaglandin synthesis.

Pregnancy

Use in pregnancy: There are no adequate and well-controlled studies in pregnant women. Optafenac 0.1% should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.Use in lactation: It is not known whether this drug is excreted in human milk. So, caution should be exercised when Optafenac 0.1% ophthalmic suspension is administered to a nursing mother.

Pediatric Uses

Use in children: Safety and effectiveness in pediatric patients below 18 years of age have not been established.Use in elderly patients: No overall differences in safety or effectiveness have been observed between elderly and younger patients.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.